CervoMed Inc.
CRVO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $19 | $20 | $4 | $30 |
| - Cash | $9 | $8 | $4 | $37 |
| + Debt | $0 | $0 | $12 | $10 |
| Enterprise Value | $10 | $13 | $12 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$18 | -$8 | -$6 | -$16 |
| % Margin | – | – | – | – |
| Net Income | -$16 | -$2 | -$6 | -$24 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.02 | -0.82 | -11.2 | -18.51 |
| % Growth | -146.3% | 92.7% | 39.5% | – |
| Operating Cash Flow | -$17 | -$7 | -$3 | -$15 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$17 | -$7 | -$3 | -$15 |